KRAS and neoplasm: Moreover, KRAS signaling can remodel the PDAC tumor microenvironment (Eser et al., 2014; Hou et al., 2020; Ohara et al., 2022).Previously, KRAS signaling leading to PDAC was considered to be “non-druggable” (Ferguson et al., 2022).